According to Nova One Advisor, the global gene editing market size is calculated at USD 11.29 billion in 2025 and is expected ...

The global community is facing a number of urgent challenges, such as emerging diseases, epidemics, antimicrobial resistance, ...

Leukon Therapeutics, Inc., a San Diego-based clinical-stage biotechnology company developing next-generation mRNA-based immunotherapies, today announced that the U.S. Food and Drug Administration (FDA ...

The legendary QB cloned his dog, Lua, who passed away in 2023. Here’s more on the process, specifics and the legality of the situation.

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...

Breakthrough Properties, a premier global life science real estate developer, today announced the completion of One Helix, a ...

Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, today announced results of an in ...

In July 2025, the FDA approved Longeveron’s Investigational New Drug (IND) application for its stem cell therapy laromestrocel as a potential treatment for pediatric dilated cardiomyopathy (DCM). The ...

Some say that what began as a modest incentive meant to foster economic development in a nascent field became a ...

According to recent market analysis, the Global Second- and Third-Generation Biofuels Market accounted for $3,574 million in 2015, and is expected to soar to $57,124 million by 2022. This exponential ...

Four quantum technology clocks developed in Australia have been tested successfully in the United States under AUKUS Pillar ...